Fluticasone Furoate and Vilanterol

Product NDC: 66993-136
11-digit product format: 669930136
Labeler code: 66993
Product ID: 66993-136_18928e94-a9ff-44a6-a65e-c6f8c21c815c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: fluticasone furoate and vilanterol
Dosage form: POWDER
Route: RESPIRATORY (INHALATION)
Labeler: Prasco Laboratories
Application: NDA204275
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2022-05-23
Substance: FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
Active strength: 200; 25 ug/1; ug/1
Pharmacologic classes: Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N204275-001	BREO ELLIPTA	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10
N204275-002	BREO ELLIPTA	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30
N204275-003	BREO ELLIPTA	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2023-05-12

Orange Book patents#

Current patent rows page 1 of 1 · 30 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N204275-001	8511304	2027-06-14	U-1424	Drug product	2013-09-06
N204275-001	8511304	2027-06-14	U-1691	Drug product	2013-09-06
N204275-001	8511304	2027-06-14	U-3623	Drug product	2013-09-06
N204275-001	8511304*PED	2027-12-14		Pediatric extension
N204275-001	11116721	2029-02-26	U-1401	Drug product	2021-10-12
N204275-001	11116721	2029-02-26	U-1691	Drug product	2021-10-12
N204275-001	11116721	2029-02-26	U-3623	Drug product	2021-10-12
N204275-001	11116721*PED	2029-08-26		Pediatric extension
N204275-001	8534281	2030-03-08		Drug product	2013-09-18
N204275-001	8534281*PED	2030-09-08		Pediatric extension
N204275-001	8746242	2030-10-11		Drug product	2014-07-08
N204275-001	8746242*PED	2031-04-11		Pediatric extension
N204275-002	8511304	2027-06-14	U-1691	Drug product	2015-05-07
N204275-002	8511304	2027-06-14	U-3623	Drug product	2015-05-07
N204275-002	8511304*PED	2027-12-14		Pediatric extension
N204275-002	11116721	2029-02-26	U-1691	Drug product	2021-10-12
N204275-002	11116721	2029-02-26	U-3623	Drug product	2021-10-12
N204275-002	11116721*PED	2029-08-26		Pediatric extension
N204275-002	8534281	2030-03-08		Drug product	2015-05-07
N204275-002	8534281*PED	2030-09-08		Pediatric extension
N204275-002	8746242	2030-10-11		Drug product	2015-05-07
N204275-002	8746242*PED	2031-04-11		Pediatric extension
N204275-003	8511304	2027-06-14	U-3623	Drug product	2023-06-09
N204275-003	8511304*PED	2027-12-14		Pediatric extension
N204275-003	11116721	2029-02-26	U-3623	Drug product	2023-06-09
N204275-003	11116721*PED	2029-08-26		Pediatric extension
N204275-003	8534281	2030-03-08		Drug product	2023-06-09
N204275-003	8534281*PED	2030-09-08		Pediatric extension
N204275-003	8746242	2030-10-11		Drug product	2023-06-09
N204275-003	8746242*PED	2031-04-11		Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 4 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N204275-001	NPP	2026-05-13
N204275-001	PED	2026-11-13
N204275-003	NS	2026-05-13
N204275-003	PED	2026-11-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 107 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2023-05-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2023-05-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204275-002	BREO ELLIPTA	0.2MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2015-04-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204275-003	BREO ELLIPTA	0.05MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD	2023-05-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204275-001	BREO ELLIPTA	0.1MG/INH;EQ 0.025MG BASE/INH	POWDER / INHALATION	RLD, RS	2013-05-10	`1e350fbaab3a…`

Observed Orange Book patent history#

Patent history page 1 of 45 · 1,785 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N204275-001	8511304	2027-06-14	U-1691	Drug product	2013-09-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8511304	2027-06-14	U-1424	Drug product	2013-09-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8511304	2027-06-14	U-3623	Drug product	2013-09-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8511304*PED	2027-12-14		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	11116721	2029-02-26	U-1401	Drug product	2021-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	11116721	2029-02-26	U-3623	Drug product	2021-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	11116721	2029-02-26	U-1691	Drug product	2021-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	11116721*PED	2029-08-26		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8534281	2030-03-08		Drug product	2013-09-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8534281*PED	2030-09-08		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8746242	2030-10-11		Drug product	2014-07-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	8746242*PED	2031-04-11		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8511304	2027-06-14	U-3623	Drug product	2015-05-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8511304	2027-06-14	U-1691	Drug product	2015-05-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8511304*PED	2027-12-14		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	11116721	2029-02-26	U-3623	Drug product	2021-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	11116721	2029-02-26	U-1691	Drug product	2021-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	11116721*PED	2029-08-26		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8534281	2030-03-08		Drug product	2015-05-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8534281*PED	2030-09-08		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8746242	2030-10-11		Drug product	2015-05-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-002	8746242*PED	2031-04-11		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8511304	2027-06-14	U-3623	Drug product	2023-06-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8511304*PED	2027-12-14		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	11116721	2029-02-26	U-3623	Drug product	2023-06-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	11116721*PED	2029-08-26		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8534281	2030-03-08		Drug product	2023-06-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8534281*PED	2030-09-08		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8746242	2030-10-11		Drug product	2023-06-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	8746242*PED	2031-04-11		Pediatric extension		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8511304	2027-06-14	U-1691	Drug product	2013-09-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8511304	2027-06-14	U-1424	Drug product	2013-09-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8511304	2027-06-14	U-3623	Drug product	2013-09-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8511304*PED	2027-12-14		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	11116721	2029-02-26	U-1401	Drug product	2021-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	11116721	2029-02-26	U-3623	Drug product	2021-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	11116721	2029-02-26	U-1691	Drug product	2021-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	11116721*PED	2029-08-26		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8534281	2030-03-08		Drug product	2013-09-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	8534281*PED	2030-09-08		Pediatric extension		`011fe1cb6892…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 3 · 96 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-08-18 06:07:40	2026-07	N204275-001	NPP	2026-05-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-001	PED	2026-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	NS	2026-05-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204275-003	PED	2026-11-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N204275-001	NPP	2026-05-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-001	PED	2026-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-003	NS	2026-05-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204275-003	PED	2026-11-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-001	NPP	2026-05-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-001	PED	2026-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-003	NS	2026-05-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204275-003	PED	2026-11-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204275-001	NPP	2026-05-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204275-001	PED	2026-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204275-003	NS	2026-05-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204275-003	PED	2026-11-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-001	NPP	2026-05-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-001	PED	2026-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-003	NS	2026-05-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204275-003	PED	2026-11-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-001	NPP	2026-05-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-001	PED	2026-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-003	NS	2026-05-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204275-003	PED	2026-11-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-001	NPP	2026-05-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-001	PED	2026-11-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-003	NS	2026-05-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204275-003	PED	2026-11-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-001	NPP	2026-05-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-001	PED	2026-11-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-003	NS	2026-05-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204275-003	PED	2026-11-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-001	NPP	2026-05-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-001	PED	2026-11-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-003	NS	2026-05-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204275-003	PED	2026-11-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-001	NPP	2026-05-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-001	PED	2026-11-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-003	NS	2026-05-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204275-003	PED	2026-11-13	`d8e5a09893c0…`

Additional Listing Data#

Finished product: Yes
Brand name base: Fluticasone Furoate and Vilanterol
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FLUTICASONE FUROATE	200 ug/1
VILANTEROL TRIFENATATE	25 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
JS86977WNV	Internal UNII lookup
40AHO2C6DG	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1424889	Internal RxNorm lookup
1648788	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3a761487-c300-451a-8537-3196c00c11b5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f4fb2f5a-dadb-40e3-a4b1-a2a58f5d9a33	Product name	3	20260126
343e8617-eb68-1e10-cfa9-8c30af285764	Product name	3	20240513
a31ad3df-8021-2ea1-94eb-0fe2f49b7729	Product name	4	20220719
c982201d-72cb-462f-9e02-902ec0d4a295	Product name	1	20181030
813fe018-3e3c-40e4-8f71-7ab50f3dfe81	Product name	2	20180723
3bcd721e-0555-4bc3-96c6-690471ff9d94	Product name	1	20171113
9f9452df-fa34-43d4-97fe-c6605344c5a8	Product name	1	20171113
0e5a25a6-9f05-44b5-8449-aa63e59f7202	Product name	1	20170426
f3c5232f-03de-44f5-996a-90cd9c08bc60	Product name	1	20170426
1cb17fbb-0da4-2841-37bc-e7079783e1a2	Product name	1	20140508
667f427a-8698-a508-767a-53ed61b4c2e9	Product name	1	20140508
6a97ffc8-1d4d-a971-4978-85ba3a22eac9	Product name	1	20140508
6df84e13-2223-fa46-1e26-17e2f58a1e1c	Product name	1	20140508
90fec588-984c-4375-cfd4-7e40114bdf80	Product name	1	20140508
9c1d3c48-b162-204b-f55b-e0f25c31c52e	Product name	1	20140508
9fdb6139-394b-1510-4baf-bde68c419789	Product name	1	20140508
aef26912-037b-9a4e-db49-225ef6dfd8f1	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66993-136-97	Fluticasone Furoate and Vilanterol	1 in 1 TRAY	POWDER	1		6
66993-136-97	Fluticasone Furoate and Vilanterol	1 in 1 CARTON	POWDER	1		6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66993-136-97	EA - Each	66993-136	f0f8d4a8-d2b3-4ee5-96ba-61dd443f2137	1	2022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66993-136	FLUTICASONE FUROATE AND VILANTEROL POWDER [PRASCO LABORATORIES]	6	Current NDC, Legacy NDC, 2 package rows	20250525_3a761487-c300-451a-8537-3196c00c11b5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fluticasone Furoate and Vilanterol	FLUTICASONE FUROATE AND VILANTEROL	Prasco Laboratories	3a761487-c300-451a-8537-3196c00c11b5	2024-11-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 204275 application number: NDA204275 ndc (product): 66993-136
Breo Ellipta	FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE	GlaxoSmithKline LLC	96428df1-ea05-431a-98d3-1ec2c4b63878	2024-11-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 204275 application number: NDA204275

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
JS86977WNV	FLUTICASONE FUROATE	397864-44-7	FLUTICASONE FUROATE
40AHO2C6DG	VILANTEROL TRIFENATATE	503070-58-4	VILANTEROL TRIFENATATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1424889	fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters	PSN	3a761487-c300-451a-8537-3196c00c11b5	6
1648788	fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters	PSN	3a761487-c300-451a-8537-3196c00c11b5	6
1424889	30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler	SCD	3a761487-c300-451a-8537-3196c00c11b5	6
1648788	30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler	SCD	3a761487-c300-451a-8537-3196c00c11b5	6
1648788	fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT	SY	3a761487-c300-451a-8537-3196c00c11b5	6
1648788	fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters	SY	3a761487-c300-451a-8537-3196c00c11b5	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
66993-136-97	66993013697	1 TRAY in 1 CARTON (66993-136-97) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER	1 tray	2022-05-23	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Fluticasone Furoate and Vilanterol - Prasco Laboratories \| GlaxoSmithKline LLC	Prasco Laboratories \| GlaxoSmithKline LLC	2024-11-21	HUMAN PRESCRIPTION DRUG LABEL	7